Shadowfax Technologies Ltd
SHADOWFAXShadowfax Technologies Ltd's multiple sits at its floor because earnings outran a hard multi-year rally — compression born of growth, not neglect. The quarters are still improving, and the P/E sits at the 1st percentile of its own 1-year range.
Biggest watch item: the price is already 25 weeks into its uptrend — timing risk, not thesis risk.
The price is in a confirmed uptrend (25 weeks in) while the P/E sits at the 1st percentile of its own 1-year range. Underneath, the last four quarters read improving — profit +712.5% year on year, and 339% of the last 2 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Shadowfax Technologies Ltd trades at ₹243, in a confirmed uptrend and 25 weeks into that stage. That is +51.5% against its own 200-day average. It sits at 100% of a 52-week range of ₹107 to ₹243. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 20 straight weeks.
Today the stock is in a confirmed uptrend — week 25 of stage 2, confirmed. At ₹243 it trades +51.5% versus its 200-day average and sits at 100% of its 52-week range (₹107–₹243).
Against the market, two honest reads. Cumulative: over the last 6 months the stock moved +122% while the NIFTY 500 moved +0% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 20 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Shadowfax Technologies Ltd trades at 84.1× P/E, about the cheapest it has ever traded. Its long-run median P/E is 263.2×, measured across 0.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 84.1× is about the cheapest it has ever traded, against a long-run median of 263.2× measured over 0.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Shadowfax Technologies Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +69.1% | +43.7% | — | — |
| Profit | +1,766.7% | — | — | — |
| EPS | +357.1% | — | — | — |
4-Factor Sector Score
57.5/100 — rank 4 of 18 in Logistics · 60% evidence confidence
Shadowfax Technologies Ltd scores 57.5 out of 100 against the 18 companies it is compared with in Logistics, ranking 4. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 30.9 + 7.5 + 9.1 + 10 = 57.5. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Shadowfax Technologies Ltd reported ₹1,358 Cr of revenue in the Jun 26 quarter, +64.8% year on year. That is the 3rd straight quarter of year-on-year growth. Over 3 years it has compounded at 43.7% a year. The last full year, FY26, came in at ₹4,202 Cr. The last four reported quarters add to ₹4,737 Cr.
FY26 revenue came in at ₹4,202 Cr (+69.1% on the year), capping 3 years at 43.7% compound. The latest quarter (Jun 26) printed ₹1,358 Cr, +64.8% year on year — the 3rd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +68.0% growth against the decade's 43.7% — the current year is running faster than its own long-run rate.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Shadowfax Technologies Ltd's operating margin is 7.0% in the Jun 26 quarter, +3.9 percentage points against the same quarter a year ago. Across 4 fiscal years the operating margin has ranged −8.0% to 5.0%. The current quarter is running above every full year in that window.
The latest quarter's operating margin is 7.0%, +3.9 pp against the same quarter a year ago. Across 4 fiscal years the operating margin has ranged −8.0%–5.0%.
Why the margin moved: operating margin went +3.7 pp year on year while gross margin went +0.0 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Shadowfax Technologies Ltd earned ₹65.0 Cr of net profit in the Jun 26 quarter, +712.5% year on year. Full-year FY26 profit was ₹112 Cr. That is 4.8% of the quarter's revenue. The same quarter a year earlier earned ₹8.0 Cr.
Jun 26 profit was ₹65.0 Cr, +712.5% year on year. On the full year, FY26 printed ₹112 Cr (+1,766.7%).
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 2 fiscal years 339% of Shadowfax Technologies Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹350 Cr of operating cash against ₹112 Cr of profit. After ₹376 Cr of capital spending, ₹−26.0 Cr was left as free cash.
FY26: operating cash of ₹350 Cr against reported profit of ₹112 Cr, leaving free cash of ₹−26.0 Cr after ₹376 Cr of capital spending. Across the last 2 fiscal years the conversion rate is 339% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 339%: the cash cycle held roughly steady between FY23 and FY26 — so conversion tracks profitability rather than the cycle.
Router verdict: the bigger cash user is investment — capital spending ran 3.4× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Shadowfax Technologies Ltd's cash conversion cycle runs 45 days in FY26, up from 40 days in FY23. Capital spending ran ₹715 Cr over the last 3 years. At FY26 sales of ₹4,202 Cr each day of that cycle holds about ₹11.5 Cr, so roughly ₹518 Cr sits inside the business at any moment.
FY26: debtors at 45 days (an asset-light business — no inventory to speak of) — for a full cycle of 45 days, looser than FY23's 40.
In money terms: at FY26 sales of ₹4,202 Cr, each day of the cycle holds about ₹11.5 Cr — so the 45-day loop keeps roughly ₹518 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹715 Cr over the last 3 fiscal years against ₹210 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹0.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Shadowfax Technologies Ltd earns a ROCE of 9% in FY26. That is up from a trough of 1% in FY24. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 2.7% net margin on 1.48× asset turns.
FY26 ROCE is 9%, recovered from a FY24 trough of 1% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 2.7% net margin × 1.48× asset turns × 1.62× balance-sheet leverage ≈ 6.5% on equity. Margin does its share; leverage is a meaningful part of the equation.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Shadowfax Technologies Ltd carries total debt of ₹247 Cr against shareholder equity of ₹1,745 Cr as of Mar 26, a debt-to-equity of 0.14 — effectively unlevered. On the annual view that ratio went from 0.20 in FY25 to 0.14 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of ₹247 Cr against shareholder equity of ₹1,745 Cr — a debt-to-equity of 0.14. On the annual view, debt-to-equity went from 0.20 (FY25) to 0.14 (FY26). The returns on this page are earned, not borrowed.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of Shadowfax Technologies Ltd moved a full percentage point over the last two years — the register is quiet. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — .
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Shadowfax Technologies Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Gateway Distriparks LtdGATEWAY | 65.8/100Favorable setup82% evidence | ASLEEP | 22.4/35 Revenue 31.5% · PAT -30.8% · OPM change 2 pp 65% evidence | 14.7/25 ROCE 10.8% · OPM 22% 100% evidence | 17.9/20 P/E 11.2× · PEG 1.18 100% evidence | 10.8/20 RS sector 0.8% · RS bench -4.3% · 1Y -10.3%1 of 10 weeks ahead 70% evidence |
| Exact sum: 22.4 + 14.7 + 17.9 + 10.8 = 65.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Aegis Logistics LtdAEGISLOG | 64.5/100Mixed-positive evidence78% evidence | BREAKING OUT | 20.9/35 Revenue 23.2% · PAT 40.5% · OPM change 0 pp 83% evidence | 17.0/25 ROCE 13.3% · OPM 24% 76% evidence | 6.6/20 P/E 51.7× · PEG — 50% evidence | 20.0/20 RS sector 50.4% · RS bench 59.1% · 1Y 74%11 of 12 weeks ahead 100% evidence |
| Exact sum: 20.9 + 17 + 6.6 + 20 = 64.5 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 3Blackbuck LtdBLACKBUCK | 57.8/100Mixed-positive evidence87% evidence | ASLEEP | 24.0/35 Revenue 48.6% · PAT 100% · OPM change -4 pp 100% evidence | 12.9/25 ROCE 12.8% · OPM 24% 100% evidence | 8.3/20 P/E 57.6× · PEG 2.09 65% evidence | 12.6/20 RS sector 22.4% · RS bench -11.1% · 1Y 16.7%0 of 9 weeks ahead 70% evidence |
| Exact sum: 24 + 12.9 + 8.3 + 12.6 = 57.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Shadowfax Technologies Ltdthis pageSHADOWFAX | 57.5/100Mixed-positive evidence60% evidence | BREAKING OUT | 30.9/35 Revenue 70.8% · PAT 1777.8% · OPM change 3.9 pp 95% evidence | 7.5/25 ROCE 9.4% · OPM 7% 95% evidence | 9.1/20 P/E 84.1× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —12 of 12 weeks ahead 0% evidence |
| Exact sum: 30.9 + 7.5 + 9.1 + 10 = 57.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5S J Logistics (India) LtdSJLOGISTIC | 56.6/100Mixed-positive evidence73% evidence | ASLEEP | 20.8/35 Revenue 67.9% · PAT 93.4% · OPM change 3 pp 71% evidence | 19.6/25 ROCE 32.4% · OPM 19% 95% evidence | 12.8/20 P/E 6.1× · PEG — 50% evidence | 3.4/20 RS sector -30.8% · RS bench -13.8% · 1Y -25.3%6 of 11 weeks ahead 70% evidence |
| Exact sum: 20.8 + 19.6 + 12.8 + 3.4 = 56.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Sical Logistics LtdSICALLOG | 54.3/100Mixed-positive evidence70% evidence | TURNING | 28.2/35 Revenue 73.9% · PAT 100% · OPM change 7.9 pp 83% evidence | 9.4/25 ROCE 9.8% · OPM 18.5% 95% evidence | 8.5/20 P/E 691× · PEG — 15% evidence | 8.2/20 RS sector -26.6% · RS bench 42.8% · 1Y 21.1%6 of 9 weeks ahead 70% evidence |
| Exact sum: 28.2 + 9.4 + 8.5 + 8.2 = 54.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7JITF Infra Logistics LtdJITFINFRA | 54.1/100Mixed-positive evidence67% evidence | TURNING | 15.9/35 Revenue 24% · PAT -80% · OPM change 1.4 pp 83% evidence | 15.7/25 ROCE 15.4% · OPM 17.7% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.5/20 RS sector -0.3% · RS bench 5.5% · 1Y -3.7%3 of 10 weeks ahead 70% evidence |
| Exact sum: 15.9 + 15.7 + 10 + 12.5 = 54.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Allcargo Terminals LtdATL | 51.9/100Mixed-positive evidence69% evidence | ASLEEP | 18.8/35 Revenue 8.3% · PAT 46.2% · OPM change 3.1 pp 62% evidence | 14.0/25 ROCE 11.6% · OPM 21.2% 95% evidence | 14.1/20 P/E 13.9× · PEG — 50% evidence | 5.0/20 RS sector -13.4% · RS bench -14% · 1Y -24%1 of 10 weeks ahead 70% evidence |
| Exact sum: 18.8 + 14 + 14.1 + 5 = 51.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Tejas Cargo India LtdTEJASCARGO | 51.4/100Thin evidence · provisional56% evidence | FADING | 15.3/35 Revenue — · PAT — · OPM change -2 pp 26% evidence | 13.9/25 ROCE 12.1% · OPM 20% 95% evidence | 9.8/20 P/E 38× · PEG — 15% evidence | 12.4/20 RS sector 16.5% · RS bench 4.9% · 1Y 8.1%10 of 11 weeks ahead 100% evidence |
| Exact sum: 15.3 + 13.9 + 9.8 + 12.4 = 51.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 10Blue Dart Express LtdBLUEDART | 49.9/100Mixed-negative evidence94% evidence | ASLEEP | 19.2/35 Revenue 9.2% · PAT 15.3% · OPM change 2 pp 100% evidence | 16.7/25 ROCE 16.6% · OPM 16% 100% evidence | 6.8/20 P/E 37.8× · PEG 3.79 100% evidence | 7.2/20 RS sector -5.9% · RS bench -6.3% · 1Y -23.6%0 of 10 weeks ahead 70% evidence |
| Exact sum: 19.2 + 16.7 + 6.8 + 7.2 = 49.9 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 11Transport Corporation of India LtdTCI | 47.7/100Mixed-negative evidence100% evidence | BASING | 15.3/35 Revenue 9.6% · PAT 7% · OPM change 0 pp 100% evidence | 16.1/25 ROCE 19.4% · OPM 11% 100% evidence | 13.3/20 P/E 15.7× · PEG 1.41 100% evidence | 3.0/20 RS sector -17.4% · RS bench -11.9% · 1Y -22.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.3 + 16.1 + 13.3 + 3 = 47.7 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 12Ritco Logistics LtdRITCO | 46.3/100Mixed-negative evidence83% evidence | LEADER | 11.9/35 Revenue 26% · PAT -21.4% · OPM change -2.4 pp 83% evidence | 8.2/25 ROCE 10.1% · OPM 5.1% 95% evidence | 8.5/20 P/E 23.2× · PEG — 50% evidence | 17.7/20 RS sector 7.2% · RS bench 14% · 1Y 0.6%12 of 12 weeks ahead 100% evidence |
| Exact sum: 11.9 + 8.2 + 8.5 + 17.7 = 46.3 · Decision use: Price leads the evidence: RS versus the benchmark is 14%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 13TransIndia Real Estate LtdTREL | 44.4/100Mixed-negative evidence83% evidence | ASLEEP | 17.5/35 Revenue 2.4% · PAT -29.8% · OPM change 41.2 pp 83% evidence | 10.5/25 ROCE 3.8% · OPM 58.3% 95% evidence | 13.7/20 P/E 16.1× · PEG — 50% evidence | 2.7/20 RS sector -17% · RS bench -11.5% · 1Y -28.2%3 of 12 weeks ahead 100% evidence |
| Exact sum: 17.5 + 10.5 + 13.7 + 2.7 = 44.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Sindhu Trade Links LtdSINDHUTRAD | 43.3/100Thin evidence · provisional58% evidence | TURNING | 15.2/35 Revenue -69.8% · PAT -52.9% · OPM change 115.5 pp 62% evidence | 5.9/25 ROCE 4.4% · OPM 4.5% 76% evidence | 9.3/20 P/E 65.5× · PEG — 15% evidence | 12.9/20 RS sector 2.9% · RS bench 0.5% · 1Y -20.2%2 of 10 weeks ahead 70% evidence |
| Exact sum: 15.2 + 5.9 + 9.3 + 12.9 = 43.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15Container Corporation Of India LtdCONCOR | 42.9/100Mixed-negative evidence100% evidence | FADING | 12.1/35 Revenue 1.7% · PAT -4% · OPM change 1 pp 100% evidence | 14.7/25 ROCE 12.4% · OPM 21% 100% evidence | 6.0/20 P/E 32.2× · PEG 3.55 100% evidence | 10.1/20 RS sector -3.9% · RS bench 2.5% · 1Y -12.2%2 of 12 weeks ahead 100% evidence |
| Exact sum: 12.1 + 14.7 + 6 + 10.1 = 42.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Western Carriers (India) LtdWCIL | 31.3/100Adverse evidence70% evidence | ASLEEP | 8.9/35 Revenue 6% · PAT -40.4% · OPM change -1.5 pp 83% evidence | 7.5/25 ROCE 6.8% · OPM 4.3% 95% evidence | 10.4/20 P/E 23.6× · PEG — 15% evidence | 4.5/20 RS sector -15% · RS bench -20.5% · 1Y -17.6%1 of 10 weeks ahead 70% evidence |
| Exact sum: 8.9 + 7.5 + 10.4 + 4.5 = 31.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Reliance Industrial Infrastructure LtdRIIL | 28.8/100Adverse evidence81% evidence | ASLEEP | 10.5/35 Revenue -16% · PAT -0.3% · OPM change -21.3 pp 95% evidence | 4.4/25 ROCE 3% · OPM -37.3% 95% evidence | 7.5/20 P/E 92.4× · PEG — 50% evidence | 6.4/20 RS sector -10.7% · RS bench -8.6% · 1Y -18.2%7 of 10 weeks ahead 70% evidence |
| Exact sum: 10.5 + 4.4 + 7.5 + 6.4 = 28.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Allcargo Gati Ltd(Merged)ACLGATI | 37.9/100Thin evidence · provisional41% evidence | 16.2/35 Revenue -1.1% · PAT 100% · OPM change -1.5 pp 27% evidence | 5.6/25 ROCE 2.2% · OPM 3.6% 57% evidence | 8.7/20 P/E 97.5× · PEG — 15% evidence | 7.4/20 RS sector -5% · RS bench -8.2% · 1Y -0.6%0 of 12 weeks ahead to 2025-11-12 70% evidence | |
| Exact sum: 16.2 + 5.6 + 8.7 + 7.4 = 37.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Shadowfax Technologies Ltd's share price today?
Shadowfax Technologies Ltd trades at ₹243. The company is valued at ₹14,217 Cr. The stock sits at 100% of its 52-week range of ₹107–₹243, +51.5% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 25 weeks in. — as of 31 July 2026.
What were Shadowfax Technologies Ltd's latest quarterly results?
Shadowfax Technologies Ltd reported revenue of ₹1,358 Cr and net profit of ₹65.0 Cr for the Jun 26 quarter. Revenue rose 64.8% and profit rose 712.5% year on year. Earnings per share were ₹1.12. The operating margin was 7.0%, 3.9 pp higher than a year earlier. — as of 31 July 2026.
What is Shadowfax Technologies Ltd's revenue?
Shadowfax Technologies Ltd reported revenue of ₹1,358 Cr in the Jun 26 quarter, +64.8% year on year. For the full FY26 fiscal year, revenue was ₹4,202 Cr (+69.1%). Over the last 3 years revenue compounded at 43.7% a year. — as of 31 July 2026.
What is Shadowfax Technologies Ltd's profit?
Shadowfax Technologies Ltd earned ₹65.0 Cr of net profit in the Jun 26 quarter, +712.5% year on year. Full-year FY26 profit was ₹112 Cr. The operating margin ran 7.0% in the latest quarter. — as of 31 July 2026.
What is Shadowfax Technologies Ltd's market cap?
Shadowfax Technologies Ltd's market capitalisation is ₹14,217 Cr at a share price of ₹243. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Shadowfax Technologies Ltd's P/E ratio?
Shadowfax Technologies Ltd trades at a P/E of 84.1×, at the 1st percentile of its own 1-year range, against a long-run median of 263.2×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Shadowfax Technologies Ltd pay a dividend?
No — Shadowfax Technologies Ltd has recorded a dividend payout of 0% of profit in each of its last 4 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 31 July 2026.
Is Shadowfax Technologies Ltd overvalued?
On its own history, Shadowfax Technologies Ltd looks cheap against its own history: its P/E of 84.1× has been cheaper only 1% of the time in 1 years (long-run median 263.2×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.
Is Shadowfax Technologies Ltd growing?
Yes — Shadowfax Technologies Ltd is growing: latest-quarter revenue +64.8% year on year, profit +712.5%, and the margin +3.9 pp at 7.0%. The earnings engine currently reads: improving — as of 31 July 2026.
How is Shadowfax Technologies Ltd performing?
Shadowfax Technologies Ltd is in a confirmed uptrend, 25 weeks in. Its latest quarter's revenue rose 64.8% and profit rose 712.5% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 20 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
Is Shadowfax Technologies Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 25 of stage 2), trading +51.5% versus its 200-day average and at 100% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Shadowfax Technologies Ltd beating the market?
On recent form, yes — Shadowfax Technologies Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 20 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 6 months the stock moved +122% against the NIFTY 500's +0% — ahead of the index over the full window. — as of 31 July 2026.
Will Shadowfax Technologies Ltd's share price go up?
This page publishes no price forecast for Shadowfax Technologies Ltd. What it measures instead: the share price is ₹243, the price is in a confirmed uptrend 25 weeks in. Its P/E of 84.1× sits at the 1st percentile of its own 1-year range. — as of 31 July 2026.
Who owns Shadowfax Technologies Ltd?
Promoters hold 16.5% of Shadowfax Technologies Ltd, foreign institutions 8.8%, domestic institutions 19.1% and the public 55.6% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 31 July 2026.
Does Shadowfax Technologies Ltd have too much debt?
No — Shadowfax Technologies Ltd's debt-to-equity is 0.14, and operating profit covers the interest bill 11×. FY26 borrowings were ₹247 Cr against equity of ₹1,745 Cr. The returns on this page are earned, not borrowed — as of 31 July 2026.
What is Shadowfax Technologies Ltd's capex?
Shadowfax Technologies Ltd spent ₹715 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹376 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is Shadowfax Technologies Ltd's cash flow?
Shadowfax Technologies Ltd generated ₹350 Cr of operating cash flow in FY26 and ₹−26.0 Cr of free cash flow after ₹376 Cr of capital spending. Reported profit that year was ₹112 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is Shadowfax Technologies Ltd's profit real cash?
Yes — over the last 2 fiscal years, 339% of Shadowfax Technologies Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹350 Cr against reported profit of ₹112 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 31 July 2026.
Where is Shadowfax Technologies Ltd in its business cycle?
Shadowfax Technologies Ltd's FY26 operating margin was 5.0%, against a 4-year band of −8.0%–5.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 7.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Shadowfax Technologies Ltd story?
Biggest watch item: the price is already 25 weeks into its uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Shadowfax Technologies Ltd a stock worth studying right now?
This is not investment advice. The machine read: Shadowfax Technologies Ltd's multiple sits at its floor because earnings outran a hard multi-year rally — compression born of growth, not neglect. The quarters are still improving, and the P/E sits at the 1st percentile of its own 1-year range. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.